Pipeline for development of acylated peptide based CGRP receptor antagonist with extended half-life for migraine treatment.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Pipeline for development of acylated peptide based CGRP receptor antagonist with extended half-life for migraine treatment.
- Published In:
- Scientific reports, 15(1), 1870 (2025)
- Authors:
- Kristensen, Jens Bjelke, Elster, Lisbeth, Lundh, Morten, Ballarín-González, Borja, Alexopoulou, Flora, Kræmer, Martin, Jensen, Ditte Marie, Leurs, Ulrike, Nielsen, Jens Christian, Hansen, Henrik H, Haanes, Kristian A, Degn, Matilda
- Database ID:
- RPEP-11929
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-11929APA
Kristensen, Jens Bjelke; Elster, Lisbeth; Lundh, Morten; Ballarín-González, Borja; Alexopoulou, Flora; Kræmer, Martin; Jensen, Ditte Marie; Leurs, Ulrike; Nielsen, Jens Christian; Hansen, Henrik H; Haanes, Kristian A; Degn, Matilda. (2025). Pipeline for development of acylated peptide based CGRP receptor antagonist with extended half-life for migraine treatment.. Scientific reports, 15(1), 1870. https://doi.org/10.1038/s41598-024-84547-1
MLA
Kristensen, Jens Bjelke, et al. "Pipeline for development of acylated peptide based CGRP receptor antagonist with extended half-life for migraine treatment.." Scientific reports, 2025. https://doi.org/10.1038/s41598-024-84547-1
RethinkPeptides
RethinkPeptides Research Database. "Pipeline for development of acylated peptide based CGRP rece..." RPEP-11929. Retrieved from https://rethinkpeptides.com/research/kristensen-2025-pipeline-for-development-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.